Abstract-Peptide libraries have proven to be useful in applications such as substrate profiling, drug candidate screening and identifying protein-protein interaction partners. However, issues of fidelity, peptide length and purity have been encountered when peptide libraries are chemically synthesized. Biochemically engineered libraries, on the other hand, circumvent many of these issues due to the fidelity of the protein synthesis machinery. Using thioredoxin as an expression partner, a stably folded peptide scaffold (avian pancreatic polypeptide) and a compatible cleavage site for human rhinovirus 3C protease, we report a method that allows robust expression of a genetically encoded peptide library, which yields peptides of high purity. In addition, we report the use of methodological synchronization, an experimental design created for the production of a library, from initial cloning to peptide characterization, within a five-week period of time.
I. INTRODUCTION
Peptide libraries are of wide interest for many applications such as identifying peptide-DNA interactions, screening for protein-protein interactions, and profiling substratespecificities thus, high-quality peptide libraries of various lengths and chemical characteristics are desirable. Typically, peptide libraries are chemically synthesized which tend to be restricted in sequence, length, and enantiomer specifications. This is due to deprotection efficiencies at each step resulting in an exponential decrease in sequence fidelity, steric clash of adjacent amino acids with bulky chemical catalysts or intermolecular aggregation which results in a low efficiency of the chemical coupling reaction [1] [2] [3] , and enantiomerization of nineteen of the twenty naturally-occurring amino acids and the associated purification difficulties [4, 5] respectively.
Genetically-encoded peptide libraries, however, can offer several advantages in library design. The resulting libraries can contain longer peptide lengths and significantly increased yields while avoiding the more common limitations of chemical synthesis. The principle advantages result from the fidelity of protein machinery, particularly because the ribosome is not limited in sequence or length of synthesized peptides and has an error rate of only 0.01% error per amino acid added [6] . In addition, expression and purification difficulties of this method have been overcome by the use of protein-expression fusion partners such as glutathione-stransferase [7] , maltose binding protein [8] and thioredoxin [9] although post expression protease processing and purification of the peptide from the protease is till required
We report a new method for expression of a geneticallyengineered peptide library of twenty-six amino acids in length that addresses the inherent challenges in both of these methods. By utilizing an experimental design that we term "methodological synchronization" we are able to produce a peptide library that rivals chemical synthesis in cost and production time, yet is insensitive to peptide length and produces more homogenous peptide samples. Our method utilizes an optimized peptide-fusion pair and coordinates mutagenesis cycles, sequencing, transformation, expression, purification and characterization steps in order to produce a library within five weeks or less.
II. RESULTS
A peptide-expression system for a twenty-member library of aPP-based peptides was engineered as thioredoxin fusion proteins. In order to streamline all steps in the process of cloning, expression and purification, the peptide designs focused on engineering an array of peptide sequences using the minimum number of rounds of DNA mutagenesis.
The parent vector was created through a single PCR reaction and a ligation reaction that resulted in the gene for a human rhinovirus 3C protease cleavage site (LEVLFQ) and a truncated avian pancreatic polypeptide (aPP) sequence which is linked to the thioredoxin fusion tag (Fig. 1). aPP variant sequences were engineered by mutating codons for six to twelve of the amino acids in the truncated 27 amino acid peptide scaffold via a QuikChange (Stratagene) mutagenesis strategy. Base constructs were engineered to include common blocks of mutations present in many peptide sequences. From these constructs, single amino acid changes that alter the charge and hydrophobicity of the site were made simultaneously to obtain the constructs with the desired variation in the sequence. If mutagenesis was performed not by sequential means, 123 rounds of mutagenesis would have been performed to complete the library. Upon sequence analysis, one out of two or more clones tested obtained the desired mutations, directly related to the thoroughness of the DpnI digestion.
The engineered DNA constructs were transformed into BL21(DE3) strain of E.coli and the fusion proteins were expressed. A nickel-affinity linear gradient purification step was employed to extract the peptide-fusion protein from E.coli lysates. A 5-hour digestion with a 1:25 protease to protein ratio was sufficient for full cleavage of peptide from the fusion tag. A three-phase HPLC purification step was then employed to purify cleaved peptide from fusion partner and human rhinovirus 3C protease. This method emerged as the timeoptimized protocol.
To verify the peptide identity and purity from the expected peptide samples, electrospray ionization mass spectrometry (ESI-MS) was performed. The spectra indicate peptides are of the expected molecular weights (3,119.1 -3,201.3 Da). In addition, the chromatogram for the liquid chromatography showed only a single peak. Averaging of spectra from all regions of the peak resulted in uniform mass spectra indicating only one molecular species was present, indicating the purified peptides are of extremely high purity. Total peptide yields ranged from 0.8 to 16%, which corresponds to 2-70 milligrams of pure peptide. Additionally, no correlation was observed between the ability to be expressed or overall yield of peptidefusions and the intrinsic chemical characteristics of the peptides, indicating that this system can be used for a wide variety of peptide sequences with a range of chemical characteristics.
III. DISCUSSION
This method of peptide production using genetically encoded peptides offers clear advantages in the length and fidelity of peptides that can be produced and the resultant purity of the final samples. Blocks of common sequence were engineered into the peptide scaffold to limit mutagenesis steps while separation of peptide from other proteins on the reverse phase HPLC limits further purification from contaminants after peptide-fusion protein purification from the lysate. The genetically-encoded production method described here was insensitive to peptide sequence such that every sequence attempted worked the first time with no optimization of expression or purification procedure required.
To this end, we have time-optimized our expression, purification and characterization protocols. Using the protocols we report and have routinely executed, we have constructed a map for methodological synchronization. By coordinating mutagenesis cycles, sequencing, transformation, expression, purification and characterization, this peptide can be produced rapidly. The methodological synchronization allows for engineering of twenty peptide-expressing plasmids and purification of the resultant peptides to homogeneity in a five-week period using one chromatography system, one HPLC and one LC-MS.
